CVS CVS Health Corporation
CVS CVS Health Corporation
Healthcare · Healthcare Plans
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $78.94 · VWAP $86.31 · +8.3% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 related campaign
CVS Price Structure
Loading timeframes…
Peers
Every watchlist CVS belongs to, members best 30-day change first — CVS highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@healthcare-scan
@healthcare
Reported the quarter ending 2026-06-30: revenue $106.10B, net income $2.98B (SEC filing). Across the print the stock moved -7.9% (close before → first close after).
full note →Against street estimates
How CVS's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about CVS from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 20 days ago · Oct 3
- CVS Health (CVS) Q2 2026 Earnings Call Transcript | The ...
- CVS Health | CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE
- CVS Health (CVS) earnings Q2 2026 - CNBC
- http://investing.com/news/transcripts/earnings-call-transcript-cvs-health-beats-q2-2026-estimates-but-shares-fall-premarket-93CH-4837765
- cvs_Ex99_1 Q2-26
CVS research tape
44 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.